Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell LymphomaFlorencia Cayrol, Leandro Cerchietti, María V. Revuelta et al.|Molecular Cancer Therapeutics|2022Cited by 6
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer GrowthMateo N. Campos Haedo, Cinthia Rosemblit, María A. Paulazo et al.|International Journal of Molecular Sciences|2024Cited by 1
Supplementary Table from Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell LymphomaFlorencia Cayrol, Leandro Cerchietti, María V. Revuelta et al.|Unknown|2023Cited by 0
Supplementary Figure from Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell LymphomaFlorencia Cayrol, Leandro Cerchietti, María V. Revuelta et al.|Unknown|2023Cited by 0
Abstract 3132: Inhibition of the integrin αVβ3 improves the effect of bexarotene in the treatment of cutaneous T-cell lymphoma (CTCL)Florencia Cayrol, Graciela Cremaschi, Victoria Revueta et al.|Cancer Research|2017Cited by 0